Tracing past population migrations: Genealogy of steroid 21-hydroxylase (CYP21) gene mutations in Finland

European Journal of Human Genetics

Volumn 7, Issue 2, 1999, Pages 188-196

  Levo, Antti ^a   Jääskeläinen, Jarmo ^b   Sistonen, Pertti ^a   Sirén, Marja Kaisa ^a   Voutilainen, Raimo ^b   Partanen, Jukka ^a  

^a FINNISH RED CROSS BLOOD SERVICE   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Congenital adrenal hyperplasia; CYP21; Finnish population history; Gene mutations; Haplotype markers; Major histocompatibility complex; Population migrations; Steroid 21 hydroxylase

Indexed keywords

STEROID 21 MONOOXYGENASE;

ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; FEMALE; FINLAND; GENE MUTATION; GENEALOGY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRATION; PRIORITY JOURNAL; STEROID 21 MONOOXYGENASE DEFICIENCY;

EID: 2442734706     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5200262     Document Type: Article

References (29)

1. Nevanlinna HR: The Finnish population structure. A genetic and genealogic study. Hereditas 1972; 71: 195-236.
2. Norio R, Nevanlinna HR, Perheentupa J: Hereditary diseases in Finland; rare flora in rare soil. Ann Clin Res 1973; 5: 109-141.
3. de la Chapelle A: Disease gene mapping in isolated human populations: the example of Finland. J Med Genet 1993; 30: 857-865.
4. Peltonen L, Pekkarinen P, Aaltonen J: Messages from an isolate: lessons from the Finnish gene pool. Biol Chem 1995; 376: 697-704.
5. Norio R: The diseases of Finland and Scandinavia. In: Rothschild HR (ed). Biocultural Aspects of Disease. Academic Press: New York, 1981, pp 359-415.
6. White PC, New MI, Dupont B: Congenital adrenal hyperplasia. N Engl J Med 1987; 316: 1519-1524.
7. Morel Y, Miller WL: Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Adv Hum Genet 1991; 20: 1-68.
8. Jääskeläinen J, Levo A, Voutilainen R, Partanen J: Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well-defined population. J Clin Endocrinol Metab 1997; 82: 3293-3297.
9. Pang S, Wallace MA, Hofman L et al: Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 1988; 81: 866-874.
10. Levo A, Partanen J: Mutation-haplotype analysis of steroid 21-hydroxylase (CYP21) deficiency in Finland. Implications for the population history of defective alleles. Hum Genet 1997; 99: 488-497.
11. Lahermo P, Sajantila A, Sistonen P et al: The genetic relationship between Finns and the Finnish Saami (Lapps): Analysis of nuclear DNA and mtDNA. Am J Hum Genet 1996; 58: 1309-1322.
12. Higashi Y, Yoshioka H, Yamane M, Gotoh O, Fujii-Kuriyama Y: Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. Proc Natl Acad Sci USA 1986; 83: 2841-2845.
13. White PC, New MI, Dupont B: Structure of human steroid 21-hydroxylase genes. Proc Natl Acad Sci USA 1986; 83: 5111-5115.
14. White PC, Tusié-Luna M-T, New MI, Speiser PW: Mutations in steroid 21-hydroxylase (CYP21). Hum Mutat 1994; 3: 373-378.
15. Partanen J, Kere J, Wessberg S, Koskimies S: Determination of deletion sizes in the MHC-linked complement C4 and steroid 21-hydroxylase genes by pulsed-field gel electrophoresis. Genomics 1989; 5: 345-349.
16. Partanen J, Koskimies S, Sipilä I, Lipsanen V: Major-histocompatibility-complex gene markers and RFLP analysis of steroid 21-hydroxylase (CYP21) and complement C4 genes in classical congenital adrenal hyperplasia patients in a single population. Am J Hum Genet 1989; 44: 660-670.
17. Campbell RD, Trowsdale J: Map of the human MHC. Immunol Today 1993; 14: 349-352.
18. Sirén MK, Sareneva H, Lokki ML, Koskimies S: Unique HLA antigen frequencies in the Finnish population. Tissue Antigens 1996; 48: 703-707.
19. Levo A, Westman P, Partanen J: An approach to mapping haplotype-specific recombination sites in human MHC class III. Immunogenetics 1996; 43: 136-140.
20. Laitinen T, Kauppi P, Ignatius J et al: Genetic control of serum IgE levels and asthma: linkage disequilibrium studies in an isolated population. Hum Mol Genet 1997; 6: 2069-2076.
21. Kuokkanen S, Sundvall M, Terwilliger JD et al: A putative vulnerability locus to multiple sclerosis maps to 5p14-p12 in a region synthetic to the murine locus Eae2. Nat Genet 1996; 13: 477-480.
22. Huurre M: 9000 vuotta Suomen esihistoriaa. 5th edn. Keuruu, Kustannusosakeyhtiö Otava, 1995.
23. Jutikkala E: Atlas of Finnish History. 2nd edn, revised. Werner Söderström Oy: Porvoo, 1959.
24. Vahtola J: The main phases of colonization in northern Finland. FARAVID, Acta Soc Hist Finland Septent 1993; 16: 141-151.
25. Sinnot PJ, Costigan C, Dyer PA, Harris R, Strachan T: Extended MHC haplotypes and CYP21/C4 gene organisation in Irish 21-hydroxylase deficiency families. Hum Genet 1991; 87: 361-366.
26. Huurre M, Virrankoski P, Vilkuna K: Suur-Kalajoen historia I. Keski-Pohjanmaan Kirjapaino Oy: Kokkola, 1956.
27. Kere J, Estivill X, Chillón M et al: Cystic fibrosis in a low-incidence population: two major mutations in Finland. Hum Genet 1994; 93: 162-166.
28. Ikäheimo I, Silvennoinen-Kassinen S, Tiilikainen A: HLA five-locus haplotypes in Finns. Eur J Immunogenet 1996; 23: 321-328.
29. Thomsen M, Barmada M, Bois M et al. MHC recombinant families. In: Charron D (ed). Genetic diversity of HLA -Functional and Medical Implication. Proceedings of the Twelfth International Histocompatibility Workshop and Conference. EDK Medical and Scientific International Publisher: Paris 1997, vol 1, pp 188-195.